- CA$50.79m
- CA$49.50m
- CA$0.15m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.54 | ||
| Price to Tang. Book | 88.51 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 362.18 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -92.34% | ||
| Return on Equity | -60.76% | ||
| Operating Margin | -6678.14% | ||
Financial Summary
| Year End 31st Jul | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 22.89 | 24.36 | 0.21 | 0.16 | 0.15 | n/a | n/a | -63.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
KDA Group Inc. is a Canada-based company focused on the development and marketing of its technological products and specialized software solutions for the healthcare market. The Company operates through Pharmaceutical Technology segment. It is focused on developing its technological products across four different platforms: KRX Medical, KRX Dental, KRX Cannabinoid and Adherize (ADRX). The KRX Dental is an electronic prescription platform assisting dentists in their practice. The KRX Medical is an electronic prescription platform assisting physicians in their practice. The KRX Cannabinoid is an electronic prescription platform assisting physicians in their practice when prescribing medical cannabis. The ADRX platform offers content allowing healthcare professionals (doctors and pharmacists) to virtually present various information. The platform includes various modules: Intelligent dialogue system, online questionnaire, pharmacist dashboard, developed algorithms, and a patient portal.
Directors
- Marc Lemieux CHM
- Sylvain Duvernay CEO
- Pierre Monet CFO
- Jean-Pierre Robert COO
- Isabelle Begin EVP
- Annie Mercier CTR
- Stan Bharti IND
- Joshua Chandler IND
- Patrick Fernet IND
- Michael Kinley IND
- David Lampron IND
- Last Annual
- July 31st, 2024
- Last Interim
- January 31st, 2025
- Incorporated
- March 6th, 2008
- Public Since
- September 9th, 2009
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
TSX Venture Exchange- Shares in Issue
- 184,699,280
- Address
- Bureau 300, 1351, rue Notre-Dame Est, THETFORD MINES, G6G 0G5
- Web
- http://www.alliancepharma.ca/
- Phone
- +1 5147150376
- Auditors
- Forvis Mazars LLP
Upcoming Events for KDA
Q3 2025 KDA Group Inc Earnings Release
Similar to KDA
Hemostemix
TSX Venture Exchange
Innovotech
TSX Venture Exchange
Marvel Biosciences
TSX Venture Exchange
Medicure
TSX Venture Exchange
MustGrow Biologics
TSX Venture Exchange
FAQ
What is the KDA share price?
As of Today at 21:32 UTC, shares in KDA are trading at CA$0.28. This share price information is delayed by 15 minutes.
How has the KDA share price performed this year?
Shares in KDA last closed at CA$0.28 and the price had moved by -37.04% over the past 365 days. In terms of relative price strength the KDA share price has underperformed the Toronto Stock Exchange 300 Composite Index by -44.02% over the past year.
What are the analyst and broker recommendations for KDA?
There is no consensus recommendation for this security.
Find out moreWhat is the KDA dividend yield?
KDA does not currently pay a dividend.
Does KDA pay a dividend?
KDA does not currently pay a dividend.
When does KDA next pay dividends?
KDA does not currently pay a dividend.
How do I buy KDA shares?
To buy shares in KDA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of KDA?
As of the previous close price of CA$0.28, shares in KDA had a market capitalisation of CA$50.79m.
Where are KDA shares listed?
Here are the trading details for KDA:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: KDA
What kind of share is KDA?
Based on an overall assessment of its quality, value and momentum KDA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a KDA share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the KDA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like KDA. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -4.34%.
As of the last closing price of CA$0.28, shares in KDA were trading +4.64% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the KDA PE Ratio?
The KDA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.28.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of KDA?
KDA's management team is headed by:
- Marc Lemieux - CHM
- Sylvain Duvernay - CEO
- Pierre Monet - CFO
- Jean-Pierre Robert - COO
- Isabelle Begin - EVP
- Annie Mercier - CTR
- Stan Bharti - IND
- Joshua Chandler - IND
- Patrick Fernet - IND
- Michael Kinley - IND
- David Lampron - IND